Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study.
Mayo Clin Proc. 1992 Aug;67(8):732-8. doi: 10.1016/s0025-6196(12)60797-6.
Mayo Clin Proc. 1992.
PMID: 1434911
Clinical Trial.